During the progression of DN disease, miR-92d-3p interacts with C3 to inhibit the activation of the C3/HMGB1/TGF-β1 pathway and EMT, thereby preventing the progression of DN renal fibrosis. The gene discussed is HMGB1; the disease is liver dysplastic nodule.